↓ Skip to main content

A systematic review of the safety information contained within the Summaries of Product Characteristics of medications licensed in the United Kingdom for Attention Deficit Hyperactivity Disorder. how…

Overview of attention for article published in Child and Adolescent Psychiatry and Mental Health, January 2012
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (78th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (55th percentile)

Mentioned by

policy
1 policy source
twitter
2 X users
googleplus
1 Google+ user

Citations

dimensions_citation
18 Dimensions

Readers on

mendeley
67 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A systematic review of the safety information contained within the Summaries of Product Characteristics of medications licensed in the United Kingdom for Attention Deficit Hyperactivity Disorder. how does the safety prescribing advice compare with national guidance?
Published in
Child and Adolescent Psychiatry and Mental Health, January 2012
DOI 10.1186/1753-2000-6-2
Pubmed ID
Authors

Nicola Savill, Chris J Bushe

Abstract

The safety of paediatric medications is paramount and contraindications provide clear pragmatic advice. Further advice may be accessed through Summaries of Product Characteristics (SPCs) and relevant national guidelines. The SPC can be considered the ultimate independent guideline and is regularly updated. In 2008, the authors undertook a systematic review of the SPC contraindications of medications licensed in the United Kingdom (UK) for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). At that time, there were fewer contraindications reported in the SPC for atomoxetine than methylphenidate and the specific contraindications varied considerably amongst methylphenidate formulations. In 2009, the European Medicines Agency (EMA) mandated harmonisation of methylphenidate SPCs. Between September and November 2011, there were three changes to the atomoxetine SPC that resulted in revised prescribing information. In addition, Clinical Guidance has also been produced by the National Institute for Health and Clinical Excellence (NICE) (2008), the Scottish Intercollegiate Guidelines Network (SIGN) (2009) and the British National Formulary for Children (BNFC).

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 67 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 1%
Israel 1 1%
Brazil 1 1%
Unknown 64 96%

Demographic breakdown

Readers by professional status Count As %
Student > Master 10 15%
Student > Bachelor 10 15%
Researcher 7 10%
Student > Doctoral Student 5 7%
Student > Ph. D. Student 5 7%
Other 13 19%
Unknown 17 25%
Readers by discipline Count As %
Medicine and Dentistry 17 25%
Psychology 15 22%
Pharmacology, Toxicology and Pharmaceutical Science 5 7%
Computer Science 2 3%
Nursing and Health Professions 2 3%
Other 4 6%
Unknown 22 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 January 2020.
All research outputs
#6,583,045
of 25,654,806 outputs
Outputs from Child and Adolescent Psychiatry and Mental Health
#344
of 791 outputs
Outputs of similar age
#53,343
of 249,976 outputs
Outputs of similar age from Child and Adolescent Psychiatry and Mental Health
#4
of 9 outputs
Altmetric has tracked 25,654,806 research outputs across all sources so far. This one has received more attention than most of these and is in the 74th percentile.
So far Altmetric has tracked 791 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.1. This one has gotten more attention than average, scoring higher than 56% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 249,976 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 78% of its contemporaries.
We're also able to compare this research output to 9 others from the same source and published within six weeks on either side of this one. This one has scored higher than 5 of them.